Logo image of PFMT

PERFORMANT HEALTHCARE INC (PFMT) Stock Fundamental Analysis

NASDAQ:PFMT - Nasdaq - US71377E1055 - Common Stock - Currency: USD

3.56  -0.12 (-3.26%)

After market: 3.56 0 (0%)

Fundamental Rating

3

Overall PFMT gets a fundamental rating of 3 out of 10. We evaluated PFMT against 103 industry peers in the Health Care Providers & Services industry. The financial health of PFMT is average, but there are quite some concerns on its profitability. PFMT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PFMT had negative earnings in the past year.
PFMT had a positive operating cash flow in the past year.
In the past 5 years PFMT always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: PFMT reported negative operating cash flow in multiple years.
PFMT Yearly Net Income VS EBIT VS OCF VS FCFPFMT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

PFMT has a worse Return On Assets (-7.99%) than 67.29% of its industry peers.
The Return On Equity of PFMT (-10.82%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -7.99%
ROE -10.82%
ROIC N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A
PFMT Yearly ROA, ROE, ROICPFMT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40

1.3 Margins

PFMT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PFMT Yearly Profit, Operating, Gross MarginsPFMT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 -10 -15

More info and screens

6

2. Health

2.1 Basic Checks

PFMT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PFMT has been increased compared to 1 year ago.
PFMT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for PFMT has been reduced compared to a year ago.
PFMT Yearly Shares OutstandingPFMT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
PFMT Yearly Total Debt VS Total AssetsPFMT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

PFMT has an Altman-Z score of 6.53. This indicates that PFMT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 6.53, PFMT belongs to the top of the industry, outperforming 89.72% of the companies in the same industry.
PFMT has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
PFMT has a Debt to Equity ratio of 0.11. This is in the better half of the industry: PFMT outperforms 72.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.53
ROIC/WACCN/A
WACC9.19%
PFMT Yearly LT Debt VS Equity VS FCFPFMT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.67 indicates that PFMT has no problem at all paying its short term obligations.
PFMT has a better Current ratio (2.67) than 85.05% of its industry peers.
A Quick Ratio of 2.67 indicates that PFMT has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.67, PFMT belongs to the best of the industry, outperforming 85.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.67
Quick Ratio 2.67
PFMT Yearly Current Assets VS Current LiabilitesPFMT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

PFMT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The Revenue has grown by 9.38% in the past year. This is quite good.
PFMT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.09% yearly.
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)9.38%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Sales Q2Q%5.2%

3.2 Future

The Earnings Per Share is expected to grow by 14.89% on average over the next years. This is quite good.
PFMT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.22% yearly.
EPS Next Y-39.4%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.54%
Revenue Next 2Y9.22%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PFMT Yearly Revenue VS EstimatesPFMT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
PFMT Yearly EPS VS EstimatesPFMT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

PFMT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PFMT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PFMT Price Earnings VS Forward Price EarningsPFMT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PFMT is valued a bit more expensive than the industry average as 64.49% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 573.95
PFMT Per share dataPFMT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PFMT's earnings are expected to grow with 14.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PFMT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PERFORMANT HEALTHCARE INC

NASDAQ:PFMT (12/17/2024, 9:22:18 PM)

After market: 3.56 0 (0%)

3.56

-0.12 (-3.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners76.31%
Inst Owner Change0.68%
Ins Owners5.33%
Ins Owner Change0%
Market Cap278.71M
Analysts82.22
Price Target7.14 (100.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.76%
Min EPS beat(2)1.96%
Max EPS beat(2)21.57%
EPS beat(4)4
Avg EPS beat(4)85.07%
Min EPS beat(4)1.96%
Max EPS beat(4)292.16%
EPS beat(8)7
Avg EPS beat(8)61.76%
EPS beat(12)10
Avg EPS beat(12)45.51%
EPS beat(16)14
Avg EPS beat(16)55.91%
Revenue beat(2)1
Avg Revenue beat(2)0%
Min Revenue beat(2)-2.19%
Max Revenue beat(2)2.2%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-2.19%
Max Revenue beat(4)3.71%
Revenue beat(8)4
Avg Revenue beat(8)-0.61%
Revenue beat(12)8
Avg Revenue beat(12)1.53%
Revenue beat(16)9
Avg Revenue beat(16)0.37%
PT rev (1m)0%
PT rev (3m)-8.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-147.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.31
P/FCF N/A
P/OCF 185.19
P/B 3.7
P/tB 10
EV/EBITDA 573.95
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.54%
SpS1.54
BVpS0.96
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.99%
ROE -10.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.17%
ROA(5y)-10.38%
ROE(3y)-9.84%
ROE(5y)-22.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 16.46
Cap/Depr 104.62%
Cap/Sales 5.74%
Interest Coverage N/A
Cash Conversion 309.67%
Profit Quality N/A
Current Ratio 2.67
Quick Ratio 2.67
Altman-Z 6.53
F-Score6
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)75.06%
Cap/Depr(5y)70.94%
Cap/Sales(3y)3.23%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y-39.4%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.38%
Revenue growth 3Y-9.98%
Revenue growth 5Y-6.09%
Sales Q2Q%5.2%
Revenue Next Year8.54%
Revenue Next 2Y9.22%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year158.93%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y0.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.02%
OCF growth 3Y-42.97%
OCF growth 5YN/A